Skip Navigation

European Heart Journal 1989 10(Supplement F):28-35; doi:10.1093/eurheartj/10.suppl_F.28
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nees, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nees, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Coronary flow increases induced by adenosine and adenine nucleotides are mediated by the coronary endothelium: a new principle of the regulation of coronary flow

S. Nees

Department of Physiology, University of Munich Munich, F.R.G.

Correspondence: S. Nees, Department of Physiology, University of Munich, Pettenkoferstrasse 12, D-8000 Munich 2, F.R.G.

Intracoronary adenosine as well as the adenine nucleotides (ATP, ADP, AMP, β, {gamma}-methylene-ATP, diadenosine-tetraphosphate, and polyadenylic acid) do not elicit their dilatory effects directly at the smooth muscle cells of the resistance vessel wall, but indirectly, via the endothelium. This must be concluded, since for these compounds the coronary endothelium represents an impermeable barrier between intra-arterial and intra-capillary spaces on the one hand, and the interstitium on the other. Furthermore, in equimolar concentrations the substances investigated induce quantitatively very similar increases in flow, although they are characterized by a highly differing metabolism during their passage through the coronary system as well as by great differences in molecular weight. These endothelium-dependent reactions cannot be influenced by 10–4M methylene blue, 10–5M haemoglobin, or pre-perfusion with 10–6M indomethacin. Accordingly, neither the EDRF nitric oxide nor PGI2 can be considered to be the mediator of these particular increases. There are now, however, observations indicating that the coronary endothelium and the smooth muscle cells of the coronary resistance vessels act as an electrically communicating ‘syncytium’. In the light of these recent discoveries, a new principle of coronary flow regulation is suggested.

Key Words: Adenosine • adenine nucleotides • coronary flow • endothelium • EDRF


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 American Journal of Medical QualityHome page
M. T. Halpern, C. S. Palmer, K. N. Simpson, F. D. Chesley, B. R. Luce, J. P. Suyderhoud, B. V. Neibauer, and F. G. Estafanous
The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients: A Decision-Analysis Model
American Journal of Medical Quality, March 1, 1998; 13(1): 3 - 12.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.